Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ì¿±À» ÀÌ¿ëÇÑ ¼ºÀο¡¼­ÀÇ »ýü °£ÀÌ½Ä Living Donor Liver Transplantation in Adults Using the Right Lobe

´ëÇѼÒÈ­±âÇÐȸÁö 2003³â 41±Ç 1È£ p.26 ~ 31
ÃÖ¼ºÈ£, ±èµ¿±¸, ¹®Àμº, À̸í´ö, ±èÀÎö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¼ºÈ£ ( Choi Sung-Ho ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

±èµ¿±¸ ( Kim Dong-Goo ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹®Àμº ( Moon In-Sung ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À̸í´ö ( Lee Myung-Duk ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÀÎö ( Kim In-Chul ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract

¸ñÀû: ¼ºÀÎÀÇ »ýüºÎºÐ °£À̽Ŀ¡¼­´Â Á¦°øÀÚÀÇ °£¿ì¿±À» ÀýÁ¦Çؼ­ ÀÌ½Ä ¼ö¼úÀ» Çϴµ¥, ¿©±â¿¡´Â Á¦°øÀÚÀÇ ¾ÈÀü¼º°ú ¼öÇýÀÚ¿¡°Ô Àû´ç·®ÀÇ À̽ÄÆíÀÌ À̽ĵǾî Á¦°øÀÚ¿Í ¼öÇýÀÚÀÇ ±ÕÇüÀ» ÀÌ·ç¾î¾ß ÇÑ´Ù. ÀúÀÚµéÀº º» º´¿øÀÇ Ãʱ⠰æÇèÀ» Á¶»çÇô¿© ÇâÈÄ Ä¡·á ¹æħÀ» °áÁ¤ÇÏ°íÀÚ ½ÃÇàÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: 2000³â 10¿ùºÎÅÍ 2001³â 9¿ù±îÁö °£¿ì¿±À» ÀÌ¿ëÇÑ ¼ºÀÇ »ýü ºÎºÐ °£ÀÌ½Ä ¼ö¼úÀÇ °æÇèÀ» ÈÄÇâÀûÀ¸·Î Á¶»çÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù. Á¦°øÀÚ´Â ´ëºÎºÐ 10´ë¿Í 20´ëÀÇ ³²ÀÚÀÌ°í ¼öÇýÀÚ´Â 40´ë¿Í 50´ëÀÇ ³²ÀÚÀε¥ ±× °ü°è´Â ÀÚ½ÄÀÌ ºÎ¸ð¿¡°Ô Á¦°øÇÑ °æ¿ì°¡ °¡Àå ¸¹¾Ò´Ù. ¼öÇýÀÚÀÇ ¿øÀÎ ÁúȯÀº ´ëºÎºÐ BÇü °£¿°¿¡ ÀÇÇÑ ¸»±â °£ºÎÀüÁõÀ¸·Î °£Á¾¾ç, °£¼º È¥¼ö, Á¤¸Æ·ù ÃâÇ÷µîÀÌ ÁÖÁõ»óÀÌ´Ù.

°á°ú: ¼ö¼ú½Ã°£Àº Á¦°øÀÚ´Â ¾à 6½Ã°£ ¹Ý, ¼öÇýÀÚ´Â ¾à 10½Ã°£ ¹Ý Á¤µµ ¼Ò¿äµÇ¾ú°í, ¼öÇ÷Àº Æò±Õ Á¦°øÀÚ´Â 1.3 unit, ¼öÇýÀÚ´Â 10.5 unitÀ̾ú´Ù. Á¦°øµÈ °£ÀÇ ¿ë·®Àº Æò±Õ 787 §¨·Î ¼öÇýÀÚ Ã¼Áß ºñ´Â 1.35%ÀÌ°í Ç¥ÁØ °£ ¿ë·®ÀÇ 67.8%¿´´Ù. Á¦°øÀÚ¿¡¼­ ¼ö¼ú ÈÄ °£È¿¼ÒÄ¡ Áõ°¡´Â ³²¾ÆÀÖ´Â °£Á¿±ÀÇ ¾çÀÌ 30% ÀÌ»óÀÎ °æ¿ì¿¡´Â Á¿±ÀÇ ¾ç¿¡ µû¸¥ Â÷ÀÌ´Â ¾ø¾úÁö¸¸ ³²¾ÆÀÖ´Â ¾çÀÌ 30% ÀÌÇÏÀÎ °æ¿ì¿¡´Â ÀÇÀÇ ÀÖ°Ô Â÷À̸¦ º¸¿´°í À§ÇèÇÑ ¼öÁصµ ÀÖ´Ù. Á¦°øÀÚ¿¡¼­ 3°³¿ù ÈÄ °£Àç»ýÀº Æò±Õ ¾à 200% Á¤µµ Àç»ýµÇ¾ú°í ³²¾ÆÀÖ´Â °£ÀÇ ¾çÀÌ ÀûÀº °æ¿ì°¡ ¸¹Àº °æ¿ìº¸´Ù ³ôÀº Àç»ý·ÂÀ» º¸¿´´Ù. ¼öÇýÀÚ´Â »ýÁ¸À²ÀÌ 89.7%·Î »ç¸ÁÁõ·Ê´Â 3¸íÀ¸·Î Á¤¸Æ·ù ÃâÇ÷, Æó¿°-±Þ¼º ÆóºÎÀüÁõ, ¹®¸ÆÇ÷ÀüÁõÀÌ ±×¿øÀÎÀÌ°í ÇÕº´ÁõÀº ¼ö¼úÀû ÇÕº´ÁõÀÌ ´ãÁó ´©Ãâ, º¹°­³» ÃâÇ÷ µîÀÌ ÀÖ°í ºñ¼ö¼úÀû ÇÕº´ÁõÀº ±Þ¼º °ÅºÎ¹ÝÀÀ, °¨¿°, ½Å°æÇÐÀû Áß»ó, ´ç´¢ µîÀÌ ÀÖ´Ù.

°á·Ð: °£¿ì¿±¿¡ ÀÇÇÑ »ýü °£À̽ÄÀº, Á¦°øÀÚ¿¡°Ô Á¦°øÀÚ ¼±ÅÃÀ» ÀßÇϸé ÇÕº´ÁõÀÌ Àû°í ºñ±³Àû ¾ÈÀüÇÑ ¼ú½ÄÀÌ°í ¼öÇýÀÚ¿¡¼­µµ »ýüºÎºÐ °£ÀÌ½Ä ¼ö¼úÀÌ »ýÁ¸À²ÀÌ ³ô°í ÇÕº´ÁõÀÌ ÀûÀº °ÍÀ¸·Î ÆǸíµÇ¾î ¸»±â °£ºÎÀüÁõ ȯÀÚ¿¡¼­ »çüÀ̽ÄÀ» ´ë½ÅÇÒ ¹æ¹ýÀ¸·Î »ý°¢µÈ´Ù.

Background/Aims: Living donor liver transplantation (LDLT) is one of the recommendable alternatives for cadaveric liver transplantation. However, it requires the balance between the graft volume and donor safety in adult patients.

Methods: We performed the LDLT using the right lobe in 29 adults at the Department of Surgery, Catholic University of Korea from Oct. 2000 to Sep. 2001. Results: The values of postoperative liver enzyme was significantly different according to the remaining liver volume of donors (<30% vs. >or=30%, P<0.05). The mean regeneration rate of the left lobe at postoperative 3 months was 212+/-43% compared to preoperative liver volume. The group that had the remaining liver volume of <35% showed a higher regenerative activity than the group that had remaining liver volume more than 35%. There was no donor mortality and postoperative complications were observed in 7 patients. The mean graft mass was 787 §¨, which was 1.35% of the recipient body weight and 67.8% of the standard liver volume. Twenty-six of 29 transplanted patients (89.7%) survived from operation. The causes of death were varix bleeding, peumonia-ARDS, and portal vein thrombosis.

Conclusion: Our preliminary data suggest that the LDLT has produced favorable results in short-term period and the survival rate is quite high for patients with end stage liver disease.

Å°¿öµå

»ýü ºÎºÐ °£À̽Ä; ¿ì¿± ÀýÁ¦¼ú; Liver transplantation; Living donor; Right lobectomy;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS